JPMORGAN CHASE & CO - TRACON PHARMACEUTICALS INC ownership

TRACON PHARMACEUTICALS INC's ticker is TCON and the CUSIP is 89237H209. A total of 36 filers reported holding TRACON PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of TRACON PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$4
-99.6%
21
-90.6%
0.00%
Q3 2021$1,000
-98.3%
223
-97.5%
0.00%
Q2 2021$58,000
+262.5%
8,972
+367.3%
0.00%
Q1 2021$16,000
-71.9%
1,920
-94.4%
0.00%
Q1 2020$57,00034,0800.00%
Other shareholders
TRACON PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Opaleye Management Inc. 4,764,508$848,0820.28%
Ikarian Capital, LLC 2,765,530$492,2650.06%
JOHNSON & JOHNSON 84,003$14,9530.01%
BOOTHBAY FUND MANAGEMENT, LLC 258,844$46,0740.00%
BlackRock Inc. 267,821$47,6730.00%
Bank of New York Mellon Corp 10,259$1,8260.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 15,835$2,8190.00%
Truvestments Capital LLC 318$570.00%
Tower Research Capital LLC (TRC) 10,407$1,8520.00%
Cutler Group LLC / CA 1,200$00.00%
View complete list of TRACON PHARMACEUTICALS INC shareholders